Drug-related administration to be reformed

The Korea Food and Drug Administration says it is contemplating a series of new measures designed to ameliorate pharmaceuticals-related regulations.

Under its new plan, any venture firm will be allowed to obtain a manufacturing license for drugs without filing a product license, which will promote the R&D efforts of biopharmaceutical companies that have suffered financial instability albeit ...